BioNTech SE (BNTX)
NASDAQ · Healthcare · Biotechnology
BioNTech SE is a Healthcare company with a market capitalization of $23.36B.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025 · in EUR
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | August 4, 2026 | $-3.03 | $-2.58 | -17.4% |
| Q1 2026 | May 5, 2026 | $-1.95 | $-1.92 | -1.6% |
| Q4 2025 | March 10, 2026 | $-0.33 | $-0.25 | -33.5% |
| Q3 2025 | November 3, 2025 | $-0.12 | $0.10 | -220.0% |
| Q2 2025 | August 4, 2025 | $-1.60 | $-1.41 | -13.5% |
| Q1 2025 | May 5, 2025 | $-1.73 | $-2.35 | +26.4% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 2,271,284 | — | 2.9 | -2.3% |
| June 30, 2026 | 2,324,296 | — | 2.8 | -15.2% |
| June 15, 2026 | 2,740,601 | — | 2.3 | +21.5% |
| May 29, 2026 | 2,255,806 | — | 2.4 | -8.0% |
| May 15, 2026 | 2,452,684 | — | 2.6 | +10.7% |
| April 30, 2026 | 2,215,111 | — | 2.5 | -31.2% |
| April 15, 2026 | 3,219,468 | — | 4.2 | -8.3% |
| March 31, 2026 | 3,509,780 | — | 3.4 | -0.8% |
Other Biotechnology Stocks
Frequently Asked Questions
What is BioNTech SE's market cap?
As of August 13, 2026, BioNTech SE (BNTX) has a market capitalization of $23.36B.
Does BioNTech SE pay a dividend?
BioNTech SE does not currently pay a dividend.
What sector is BNTX in?
BioNTech SE is in the Healthcare sector, specifically the Biotechnology industry.
What is BioNTech SE's short interest?
As of the July 15, 2026 FINRA settlement, 2,271,284 BNTX shares were sold short. Days to cover: 2.9. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was BioNTech SE's revenue?
In its latest reported fiscal year (ending December 31, 2025), BioNTech SE reported revenue of 2.76B EUR and net income of -1.09B EUR.
Ask your own questions about BNTX
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.